Business Description
Bio-Rad Laboratories Inc
NAICS : 334516
SIC : 3826
1000 Alfred Nobel Drive, Hercules, CA, USA, 94547
Description
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.41 | |||||
Equity-to-Asset | 0.7 | |||||
Debt-to-Equity | 0.16 | |||||
Debt-to-EBITDA | -0.57 | |||||
Interest Coverage | 33.26 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 3.39 | |||||
Beneish M-Score | -2.84 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 8.5 | |||||
3-Year EBITDA Growth Rate | 102.2 | |||||
3-Year EPS without NRI Growth Rate | 126.5 | |||||
3-Year FCF Growth Rate | 51 | |||||
3-Year Book Growth Rate | 50.1 | |||||
Future 3-5Y EPS without NRI Growth Rate Industry Rank | 8.41 | |||||
Future 3-5Y Total Revenue Growth Rate Industry Rank | 5.95 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 60.01 | |||||
9-Day RSI | 58.56 | |||||
14-Day RSI | 57.71 | |||||
6-1 Month Momentum % | -20.56 | |||||
12-1 Month Momentum % | -34.73 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.3 | |||||
Quick Ratio | 4.22 | |||||
Cash Ratio | 3.21 | |||||
Days Inventory | 178.96 | |||||
Days Sales Outstanding | 54.79 | |||||
Days Payable | 43.26 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.1 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 57.05 | |||||
Operating Margin % | 18.37 | |||||
Net Margin % | -67.66 | |||||
ROE % | -16.27 | |||||
ROA % | -12.15 | |||||
ROIC % | 2.79 | |||||
ROC (Joel Greenblatt) % | -206.42 | |||||
ROCE % | -16.9 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 21.94 | |||||
PS Ratio | 5.75 | |||||
PB Ratio | 1.83 | |||||
Price-to-Tangible-Book | 1.96 | |||||
Price-to-Free-Cash-Flow | 45.52 | |||||
Price-to-Operating-Cash-Flow | 34.14 | |||||
EV-to-EBIT | -6 | |||||
EV-to-Forward-EBIT | 21.44 | |||||
EV-to-EBITDA | -6.32 | |||||
EV-to-Forward-EBITDA | -13.61 | |||||
EV-to-Revenue | 5.42 | |||||
EV-to-Forward-Revenue | 5.5 | |||||
EV-to-FCF | 42.8 | |||||
Price-to-Projected-FCF | 1.67 | |||||
Price-to-Median-PS-Value | 1.82 | |||||
Earnings Yield (Greenblatt) % | -16.67 | |||||
Forward Rate of Return (Yacktman) % | 21.8 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Gurus Latest Trades with NYSE:BIO
Executives
EMBED
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 2,870.979 | ||
EPS (TTM) ($) | -66.32 | ||
Beta | 0.78 | ||
Volatility % | 34.16 | ||
14-Day RSI | 57.71 | ||
14-Day ATR ($) | 17.552444 | ||
20-Day SMA ($) | 534.126 | ||
12-1 Month Momentum % | -34.73 | ||
52-Week Range ($) | 462.61 - 832.7 | ||
Shares Outstanding (Mil) | 29.7 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Bio-Rad Laboratories Inc Filings
Document | Form | Filing Date | ||
---|---|---|---|---|
No Filing Data |